Exact Mass: 289.1790178

Exact Mass Matches: 289.1790178

Found 48 metabolites which its exact mass value is equals to given mass value 289.1790178, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-Hydroxyheptanoylcarnitine

3-[(3-Hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C14H27NO5 (289.1889132)


3-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyheptanoylcarnitine

3-[(5-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO5 (289.1889132)


5-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Hydroxyheptanoylcarnitine

3-[(4-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO5 (289.1889132)


4-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyheptanoylcarnitine

3-[(6-Hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C14H27NO5 (289.1889132)


6-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Dimethylphysostigmine

1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N,N-dimethylcarbamate

C16H23N3O2 (289.1790178)


   

trimethylamino-diphenylhexatriene

3,4,5-trimethyl-1,1-diphenylhexa-1,3,5-trien-2-amine

C21H23N (289.1830398)


   

trimethylaminodiphenylhexatriene

2,3,6-trimethyl-4-(1-phenylhexa-1,3,5-trien-1-yl)aniline

C21H23N (289.1830398)


   
   

3-isopropenyl-7,7-dimethyl-8-(3-methyl-but-2-enoyl)-2,6,7,8-tetrahydro-3H-imidazo[1,2-a]pyrimidin-5-one|Alchornidin|Alchornidine

3-isopropenyl-7,7-dimethyl-8-(3-methyl-but-2-enoyl)-2,6,7,8-tetrahydro-3H-imidazo[1,2-a]pyrimidin-5-one|Alchornidin|Alchornidine

C16H23N3O2 (289.1790178)


   
   

1-Phenoxy-5,5-dimethyl-3-(1H-1,2,4-triazol-1-yl)-4-hexanol

1-Phenoxy-5,5-dimethyl-3-(1H-1,2,4-triazol-1-yl)-4-hexanol

C16H23N3O2 (289.1790178)


   

N,N-BIS(T-BUTYL-4-CARBOXYMETHYL)AMINOETHANOL

N,N-BIS(T-BUTYL-4-CARBOXYMETHYL)AMINOETHANOL

C14H27NO5 (289.1889132)


   

BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

C16H23N3O2 (289.1790178)


   

1-λ1-oxidanyl-2,2,5,5-tetramethyl-N-(1,3,4-trihydroxybutan-2-yl)pyrrolidine-3-carboxamide

1-λ1-oxidanyl-2,2,5,5-tetramethyl-N-(1,3,4-trihydroxybutan-2-yl)pyrrolidine-3-carboxamide

C13H25N2O5 (289.176338)


   

4-Morpholinophenylboronic Acid Pinacol Ester

4-Morpholinophenylboronic Acid Pinacol Ester

C16H24BNO3 (289.1849144)


   

N,N-dimethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

N,N-dimethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

C16H24BNO3 (289.1849144)


   

N-ethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

N-ethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

C16H24BNO3 (289.1849144)


   

N-Acetyl-3-(4-(p-methoxyphenyl)piperazinyl)azetidine

N-Acetyl-3-(4-(p-methoxyphenyl)piperazinyl)azetidine

C16H23N3O2 (289.1790178)


   
   
   

Tributylphosphonium tetrafluoroborate

Tributylphosphonium tetrafluoroborate

C12H27BF4P (289.187945)


   

2-(CYCLOPENTYLOXY)-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-(CYCLOPENTYLOXY)-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C16H24BNO3 (289.1849144)


   

N,N,4-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N,N,4-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C16H24BNO3 (289.1849144)


   

2-(CYCLOPENTYLOXY)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-(CYCLOPENTYLOXY)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C16H24BNO3 (289.1849144)


   

3-morpholinophenylboronic acid pinacol ester

3-morpholinophenylboronic acid pinacol ester

C16H24BNO3 (289.1849144)


   

2-(3,5-Dimethylphenyl)-5-Isobutylquinoline

2-(3,5-Dimethylphenyl)-5-Isobutylquinoline

C21H23N (289.1830398)


   

N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

C16H24BNO3 (289.1849144)


   

(1-PIPERIDIN-4-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(1-PIPERIDIN-4-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C16H23N3O2 (289.1790178)


   

(1-PIPERIDIN-3-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(1-PIPERIDIN-3-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C16H23N3O2 (289.1790178)


   

benzyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

benzyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

C16H23N3O2 (289.1790178)


   

trimethylaminodiphenylhexatriene

trimethylaminodiphenylhexatriene

C21H23N (289.1830398)


   

trimethylamino-diphenylhexatriene

trimethylamino-diphenylhexatriene

C21H23N (289.1830398)


   

5-Hydroxyheptanoylcarnitine

5-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889132)


   

4-Hydroxyheptanoylcarnitine

4-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889132)


   

6-Hydroxyheptanoylcarnitine

6-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889132)


   

(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(Z)-11-methyl-N-(methylsulfonyl)dodec-2-enamide

(Z)-11-methyl-N-(methylsulfonyl)dodec-2-enamide

C14H27NO3S (289.17115520000004)


   

An isonitrile lipopetide

An isonitrile lipopetide

C12H25N4O4+ (289.187571)


   

2-(3-(4-N,N-Dimethylaminophenyl)propyl)naphthalene

2-(3-(4-N,N-Dimethylaminophenyl)propyl)naphthalene

C21H23N (289.1830398)


   

3-Hydroxyheptanoylcarnitine

3-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889132)


   
   

7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

C16H23N3O2 (289.1790178)


   

(3r)-7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

(3r)-7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

C16H23N3O2 (289.1790178)